Envestnet Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Buy |
23,878
+7,199
| +43% | +$398K | ﹤0.01% | 3098 |
|
|
2025
Q1 | $807K | Buy |
16,679
+7,698
| +86% | +$372K | ﹤0.01% | 3339 |
|
|
2024
Q4 | $347K | Sell |
8,981
-3,802
| -30% | -$147K | ﹤0.01% | 3813 |
|
|
2024
Q3 | $575K | Sell |
12,783
-776
| -6% | -$34.9K | ﹤0.01% | 3468 |
|
|
2024
Q2 | $470K | Buy |
13,559
+2,390
| +21% | +$82.8K | ﹤0.01% | 3494 |
|
|
2024
Q1 | $323K | Buy |
+11,169
| New | +$323K | ﹤0.01% | 3686 |
|